- £4.00bn
- £4.78bn
- $2.88bn
- 74
- 49
- 69
- 72
REG - Hikma Pharmaceutical - Holding(s) in Company
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - J.P. Morgan Sec PLC Hikma Pharmaceutical - Result of placing in Hikma Pharmaceuticals PLC
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - J.P. Morgan Sec PLC Hikma Pharmaceutical - Proposed Placing in Hikma Pharmaceuticals PLC
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Hikma receives FDA approval for generic Vascepa®
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Total Voting Rights
AnnouncementREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Directorate Change
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - AGM Update
Announcement